-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Empower Clinics Announces New Auditor and Change of Year End
Empower Clinics Announces New Auditor and Change of Year End
VANCOUVER, BC / ACCESSWIRE / December 23, 2022 / EMPOWER CLINICS INC (CSE:EPW)(OTC PINK:EPWCF) ("Empower" or the "Company") an integrated healthcare company - serving patients through medical centers, a medical device company and a high complexity medical diagnostics laboratory is pleased to announce the appointment of Zeifmans LLP ("Zeifmans") as its new auditor effective December 20, 2022, and announces the change of its year end to March 31st.
Zeifmans replaces MNP LLP ("MNP") as Empower's auditor. The board of directors (the "Board") and management of Empower would like to thank MNP for their services. The change in auditor has been approved by the Company's audit committee and the Board.
There was no modified opinion expressed in Zeifmans' report on any of the Company's financial statements relating to the period commencing at the beginning of the Company's two most recently completed financial years and ending on the date of resignation of MNP. There have been no "reportable events" within the meaning assigned under subsection 4.11(1) of National Instrument 51‐102 Continuous Disclosure Obligations.
The Company today also announces the change of its year end from December 31 to March 31.
"These are important milestones for our Company, that are intended to ensure we improve our accounting, audit and financial controls going forward," stated Steven McAuley, Chairman & CEO. "Zeifmans have decades of technical accounting and audit experience, and came with tremendous trade references from other issuers in Canada."
This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions, and engagement with management
ABOUT EMPOWER:
Empower is an integrated healthcare company with multi-disciplinary clinics, an at-home medical testing device company and state-of-the-art medical diagnostics laboratories. With a growing presence in the U.S. and Canada. Empower is a leader in integrated healthcare and diagnostics solutions and is reshaping the model for patient-first wellness.
ON BEHALF OF THE BOARD OF DIRECTORS:
Steven McAuley
Chief Executive Officer
CONTACTS:
Media:
Steven McAuley CEO
s.mcauley@empowerclinics.com
+1 855-855-9058
Investors:
Tamara Mason
Business Development & Communications
t.mason@empowerclinics.com
+1 855-855-9058
DISCLAIMER FOR FORWARD-LOOKING STATEMENTS
This news release contains certain "forward-looking statements" or "forward-looking information" (collectively "forward looking statements") within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as "plans", "continues", "expects", "projects", "intends", "believes", "anticipates", "estimates", "may", "will", "potential", "proposed" and other similar words, or information that certain events or conditions "may" or "will" occur. Such forward-looking statements are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements. No assurance can be given that any of the events anticipated by the forward-looking statements will occur on the terms or in the time expected, or at all, or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities laws.
SOURCE: Empower Clinics Inc.
View source version on accesswire.com:
VANCOUVER, BC / ACCESSWIRE / December 23, 2022 / EMPOWER CLINICS INC (CSE:EPW)(OTC PINK:EPWCF) ("Empower" or the "Company") an integrated healthcare company - serving patients through medical centers, a medical device company and a high complexity medical diagnostics laboratory is pleased to announce the appointment of Zeifmans LLP ("Zeifmans") as its new auditor effective December 20, 2022, and announces the change of its year end to March 31st.
溫哥華,BC/ACCESSWIRE/2022年12月23日/Empower Clinics Inc.(CSE:EPW)(場外PINK:EPWCF)("增強能力“或”公司)一家通過醫療中心、一家醫療器械公司和一家高複雜性醫療診斷實驗室為患者提供服務的綜合醫療保健公司高興地宣佈任命Zeifman LLP(澤伊夫曼“)為其新的審計師,自2022年12月20日起生效,並宣佈將其年終改為3月31日。
Zeifmans replaces MNP LLP ("MNP") as Empower's auditor. The board of directors (the "Board") and management of Empower would like to thank MNP for their services. The change in auditor has been approved by the Company's audit committee and the Board.
蔡夫曼取代了MNP LLP(“MNP“)作為授權的審計師。董事會(The”衝浪板“)和Empower的管理層感謝MNP的服務。更換審計師的決定已得到公司審計委員會和董事會的批准。
There was no modified opinion expressed in Zeifmans' report on any of the Company's financial statements relating to the period commencing at the beginning of the Company's two most recently completed financial years and ending on the date of resignation of MNP. There have been no "reportable events" within the meaning assigned under subsection 4.11(1) of National Instrument 51‐102 Continuous Disclosure Obligations.
澤伊曼斯公司的報告中沒有對公司最近兩個財政年度開始至MNP辭職之日止期間的任何財務報表發表任何修改意見。在《國家文書51-102連續披露義務》第4.11(1)節中所指定的含義內,並未出現“需要報告的事件”。
The Company today also announces the change of its year end from December 31 to March 31.
該公司今天還宣佈將其年終日期從12月31日改為3月31日。
"These are important milestones for our Company, that are intended to ensure we improve our accounting, audit and financial controls going forward," stated Steven McAuley, Chairman & CEO. "Zeifmans have decades of technical accounting and audit experience, and came with tremendous trade references from other issuers in Canada."
董事長兼首席執行官史蒂文·麥考利說:“這些都是我們公司的重要里程碑,旨在確保我們今後改進我們的會計、審計和財務控制。Zeifman擁有數十年的技術會計和審計經驗,並從加拿大其他發行人那裡獲得了大量的貿易參考資料。
This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions, and engagement with management
本新聞稿可在AGORACOM上的授權診所驗證論壇上獲取,以供股東討論、提問和與管理層接觸
ABOUT EMPOWER:
關於授權:
Empower is an integrated healthcare company with multi-disciplinary clinics, an at-home medical testing device company and state-of-the-art medical diagnostics laboratories. With a growing presence in the U.S. and Canada. Empower is a leader in integrated healthcare and diagnostics solutions and is reshaping the model for patient-first wellness.
Empower是一家綜合性醫療保健公司,擁有多學科診所、家用醫療檢測設備公司和最先進的醫療診斷實驗室。在美國和加拿大的影響力越來越大。Empower是集成醫療保健和診斷解決方案的領先者,正在重塑患者至上的健康模式。
ON BEHALF OF THE BOARD OF DIRECTORS:
我謹代表董事會:
Steven McAuley
Chief Executive Officer
史蒂文·麥考利
首席執行官
CONTACTS:
聯繫人:
Media:
媒體:
Steven McAuley CEO
s.mcauley@empowerclinics.com
+1 855-855-9058
史蒂文·麥考利首席執行官
郵箱:s.mcauley@empower Clinics.com
+1 855-855-9058
Investors:
投資者:
Tamara Mason
塔瑪拉·梅森
Business Development & Communications
t.mason@empowerclinics.com
+1 855-855-9058
業務發展與溝通
郵箱:t.mason@empower Clinics.com
+1 855-855-9058
DISCLAIMER FOR FORWARD-LOOKING STATEMENTS
對前瞻性陳述的免責聲明
This news release contains certain "forward-looking statements" or "forward-looking information" (collectively "forward looking statements") within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as "plans", "continues", "expects", "projects", "intends", "believes", "anticipates", "estimates", "may", "will", "potential", "proposed" and other similar words, or information that certain events or conditions "may" or "will" occur. Such forward-looking statements are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements. No assurance can be given that any of the events anticipated by the forward-looking statements will occur on the terms or in the time expected, or at all, or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities laws.
本新聞稿包含適用於加拿大證券法的某些“前瞻性陳述”或“前瞻性資訊”(統稱為“前瞻性陳述”)。除有關歷史事實的陳述外,所有陳述均為前瞻性陳述,均基於截至本新聞稿發佈之日的預期、估計和預測。前瞻性表述常常可以用“計劃”、“繼續”、“預期”、“專案”、“打算”、“相信”、“預期”、“估計”、“可能”、“將”、“潛在”、“建議”和其他類似詞語,或某些事件或條件“可能”或“將”發生的資訊來識別。此類前瞻性陳述是基於管理層目前已知的假設,會受到風險和不確定因素的影響,這些風險和不確定性可能會導致實際結果、業績或發展與前瞻性陳述中包含的大不相同。不能保證前瞻性陳述中預期的任何事件將按照預期的條款或時間發生,或者根本不能保證,或者如果發生了,公司將從中獲得什麼好處。告誡讀者不要過度依賴本新聞稿中的前瞻性陳述,這些前瞻性陳述完全受這些警告性陳述的限制。除適用的證券法明確要求外,公司沒有義務更新或修改本新聞稿中的任何前瞻性陳述,除非適用的證券法明確要求,無論是由於新資訊、未來事件還是其他原因。
SOURCE: Empower Clinics Inc.
資料來源:Empower Clinics Inc.
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧